Accelerate Diagnostics: Funding, Investors & Team (Oct 2026)
Accelerate Diagnostics is a medical device company dedicated to providing solutions to the global challenge of drug-resistant organisms and hospital-acquired infections. It is focused on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The Company’s revolutionary BACcel platform utilizes a proprietary culture-free process, with both genomic and phenotypic detection technologies, that significantly decreases time to result while achieving high sensitivity and specificity. It was founded in 2004 and is headquartered in Tucson, Arizona.
Accelerate Diagnostics has raised $4.0M across 1 funding round on record, the most recent a Post-IPO Equity of $4.0M announced in Apr 2022.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Accelerate Diagnostics Company Profile and Key Stats
Latest funding round on record: Apr 2022.
Accelerate Diagnostics Funding Rounds
Accelerate Diagnostics Founders and Leadership Team
No contact details are on record for this team yet.
Accelerate Diagnostics Funding Compared to Other Health Care Startups
Accelerate Diagnostics' latest round of $4.0M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Accelerate Diagnostics in Health Care and Tucson
Companies Similar to Accelerate Diagnostics
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Accelerate Diagnostics Funding FAQs
What does Accelerate Diagnostics do?
Accelerate Diagnostics is a medical device company dedicated to providing solutions to the global challenge of drug-resistant organisms and hospital-acquired infections. It is focused on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The Company’s revolutionary BACcel platform utilizes a proprietary culture-free process, with both genomic and phenotypic detection technologies, that significantly decreases time to result while achieving high sensitivity and specificity. It was founded in 2004 and is headquartered in Tucson, Arizona.
How much funding has Accelerate Diagnostics raised?
Accelerate Diagnostics has raised $4.0M across 1 round on record. The most recent is a Post-IPO Equity of $4.0M announced in Apr 2022.
When did Accelerate Diagnostics last raise funding?
Accelerate Diagnostics' most recent funding round on record is a Post-IPO Equity of $4.0M, announced in Apr 2022.
Who is the CEO of Accelerate Diagnostics?
Jack Phillips is listed as CEO at Accelerate Diagnostics.
Where is Accelerate Diagnostics headquartered?
Accelerate Diagnostics is based in Tucson, Arizona, United States.
How many employees does Accelerate Diagnostics have?
Accelerate Diagnostics is in the 101-250 employee band.
How does Accelerate Diagnostics' funding compare to other Health Care startups?
Accelerate Diagnostics' latest round of $4.0M is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Accelerate Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Accelerate Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.